Science Daily

Monday th 14th of November 2011

Novel nanocrystals with advanced optical properties developed for use as luminescent biomarkers - 10:30

Violent passions: Jealous cleaner shrimp murder their rivals - 00:30

Rising air pollution worsens drought, flooding, new study finds - 00:30

Tarantula Nebula glows with X-rays and infrared light - 00:30

Sunday th 13th of November 2011

Wearable defibrillator can prevent death in people with arrhythmias, research finds - 23:30

Prenatal exposure to environmental pollutants may affect weight and size of newborn - 20:30

Intensive diabetes therapy protects Type 1 diabetics' kidneys - 16:31

Benefit of novel drug in breast cancer seen in blood within weeks - 16:30

Signaling pathway linked to inflammatory breast cancer may drive disease metastasis - 16:30

A more flexible window into the brain - 15:30

New way to target – and kill – proliferating tumors - 15:30

Tamoxifen resistance -- and how to defeat it - 15:30

Climate policies can help resolve energy security and air pollution challenges - 15:30

Saturday th 12th of November 2011

Prototype hand-held drug testing device launched - 16:32

New turkey feed helps bird producers gobble up profits - 16:32

Study helps eliminate causes for joint pain linked to commonly used breast cancer drugs - 16:32

Elderly emergency patients less likely to receive pain medication than middle-aged patients - 16:32

Chemistry: New insight into 100-year-old Haber-Bbosch process of converting nitrogen to ammonia - 16:32

Depression in young people increases risk of heart disease mortality - 16:31

Researching graphene nanoelectronics for a post-silicon world - 15:30

Storm chasers of Utah - 15:30

Adoptive parents put through wringer, Australian report finds - 15:30

Friday th 11th of November 2011

Mid-ocean creatures control light to avoid becoming snacks - 17:30

Coneheads (Protura) of Italy: What we know in their 'native' country after a century - 17:30

Citrus indica Tanaka: A progenitor species of cultivated Citrus - 17:30

Catching camels in the Gobi - 17:30

2012: Killer solar flares are a physical impossibility - 17:30

Researchers closer to the super bug puzzle - 17:30

Birth weight predicts physical functioning at age 60 - 16:31

New system of intelligent management of street lighting enables 80% savings in energy - 16:31

Lutetia: A rare survivor from the birth of Earth - 16:31

Gene switch for odorant receptors - 16:31

Eating fish can reduce the risk of diabetes - 16:31

Diseased hearts to heal themselves in future - 16:31

Study suggests new benefits of eating nuts for patients with metabolic syndrome - 16:31

Tales from the crypt: Study on gut cell regeneration reconciles long-standing research controversy - 16:31

Vanishing act creates a stir in the nanotech world: Sheets made of microscopic carbon fibers seem to disappear when heated - 01:30

Kawasaki disease linked to wind currents: First evidence that long-range wind transport of an infectious agent might result in human disease - 00:30

Elderly lose ability to distinguish between odors, researcher finds; Smells blend together, pose hazards - 00:30

Acupuncture can prevent radiation-induced chronic dry mouth, study finds - 00:30

Why do neurons die in Parkinson's disease? Study of hereditary Parkinson’s finds that mitochondria can’t be cleared out when damaged - 00:30

Volunteering, helping others decreases substance use in rural teens, study finds - 00:30

Effects of 'mini stroke' can shorten life expectancy - 00:30

Thursday th 10th of November 2011

Patients with acute coronary syndrome and/or diabetes who show poor response to dual antiplatelet therapy as measured by platelet function testing are at greater risk of stent thrombosis after percutaneous coronary intervention with drug-eluting stents - 21:30

Risk of late stent thrombosis continues for up to seven years in patients with first generation drug-eluting stents; risk factors identified - 21:30

Non-adherence to dual antiplatelet therapy following percutaneous coronary intervention results in higher rates of ischemic and bleeding events - 21:30

Clinical trial comparing prasugrel to clopidogrel following percuataneous coronary intervention is ended early due to overall low rate of primary endpoint clinical events - 21:30

Tailored therapy for anti-platelet drugs using a novel point-of-care genetic test provides improved response to medications compared to current standard of care - 21:30

Cangrelor provides effective maintenance of platelet inhibition without major bleeding for patients who require bypass surgery, results show - 21:30

Risk-taking behavior rises until age 50 - 21:30